BNP Paribas Asset Management’s Loxo Oncology, Inc LOXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-90,971
Closed -$12.2M 950
2018
Q4
$12.2M Sell
90,971
-2,952
-3% -$448K 0.11% 253
2018
Q3
$16M Buy
93,923
+13,778
+17% +$2.32M 0.12% 231
2018
Q2
$13.9M Sell
80,145
-39,495
-33% -$5.94M 0.12% 257
2018
Q1
$13.8M Buy
+119,640
New +$12.7M 0.12% 244

Other funds holding LOXO

BNP Paribas Asset Management's LOXO Position: Q1 2019 in Review

BNP Paribas Asset Management sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 90,971 shares — an estimated $12.2M sold.

BNP Paribas Asset Management first reported a position in LOXO in Q1 2018 and held it in 4 quarters. The position peaked at $16M in Q3 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

  • BNP Paribas Asset Management reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
  • BNP Paribas Asset Management sold 90,971 Loxo Oncology, Inc shares in Q1 2019, an estimated $12.2M.
  • BNP Paribas Asset Management first reported a position in Loxo Oncology, Inc in Q1 2018 and held it in 4 quarters.
  • BNP Paribas Asset Management's Loxo Oncology, Inc position peaked at $16M in Q3 2018.
  • 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on BNP Paribas Asset Management's 13F filing for Q1 2019, filed 26 Apr 2019.